|
Personalized biomarkers to monitor disease Probing gender-specific change in IgG1 Fc-galactosylation in non-small cell lung cancer patients treated with epidermal growth factor receptor inhibitor, icotinib hydrochloride, using MALDI-FTICR MS |
|
CHEN Guoqiang 1,ZHANG Li 2,WANG Yanying 1,GUO Yumei 1,LIU Hui 1,LI Zhili 1 * #
|
|
1.Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, 100005
|
2.Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100730
|
|
*Correspondence author |
#Submitted by |
|
Subject: |
Funding:
Research Fund National Natural Science Foundation of China (No.No. 21075137), Research Fund for the Doctoral Program of Higher Education (No.No. 20121106110023)) |
Opened online:16 May 2016 |
Accepted by:
none |
Citation: CHEN Guoqiang,ZHANG Li,WANG Yanying.Personalized biomarkers to monitor disease Probing gender-specific change in IgG1 Fc-galactosylation in non-small cell lung cancer patients treated with epidermal growth factor receptor inhibitor, icotinib hydrochloride, using MALDI-FTICR MS[OL]. [16 May 2016] http://en.paper.edu.cn/en_releasepaper/content/4688123 |
|